AstraZeneca and Oxford defend Covid vaccine trials after questions raised in US – MSNNOW
Former U.S. pharmaceutical executives raised questions this week about the Oxford-AstraZeneca vaccine candidate, the developers of which have calculated its combined results to be 70% effective based on published phase three trial data. Monday. “We believe that this product will never be approved in the United States,” wrote a group of critical analysts based in […]
The post AstraZeneca and…